The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Favistan     1-methyl-3H-imidazole-2-thione

Synonyms: Mercazol, Methizol, Tapazole, Thimazol, Thyrozol, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Strumazol


Psychiatry related information on Strumazol


High impact information on Strumazol


Chemical compound and disease context of Strumazol


Biological context of Strumazol


Anatomical context of Strumazol


Associations of Strumazol with other chemical compounds


Gene context of Strumazol

  • Activity studies were done with two selective functional FMO substrates, methimazole, and 10-(N,N-dimethylaminopentyl)-2-(trifluoromethyl)phenothiazine and exon 3- (exon 4 for FMO4) deleted FMOs were not able to catalyze the S- and N-oxygenation of these substrates, respectively [30].
  • Methimazole (MMI) and PTU had similar potencies in inhibiting the TPO-catalyzed coupling reaction, whereas MMI was distinctly more potent than PTU as an inhibitor of TPO-mediated iodination in vitro [31].
  • In addition, serum anti-TSH receptor antibody levels were directly correlated with the absolute numbers of T cells bound to IL-2 (r = 0.565, P < 0.05) and to IL-6 (r = 0.653), P = 0.02) in the hyperthyroid untreated patients, but not in long-term remission euthyroid GD patients or in patients treated with methimazole [32].
  • Following antithyroid drug treatment with methimazole, GH responses to GHRH increased in these patients in comparison to pretreatment values [33].
  • Our results show that methimazole therapy downregulates the abnormally high expression of the CD69 early activation antigen on T cells, being less effective on inducing changes in other T cell activation markers and in NK cells [34].

Analytical, diagnostic and therapeutic context of Strumazol


  1. Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease. Tötterman, T.H., Karlsson, F.A., Bengtsson, M., Mendel-Hartvig, I. N. Engl. J. Med. (1987) [Pubmed]
  2. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. Bartalena, L., Marcocci, C., Bogazzi, F., Manetti, L., Tanda, M.L., Dell'Unto, E., Bruno-Bossio, G., Nardi, M., Bartolomei, M.P., Lepri, A., Rossi, G., Martino, E., Pinchera, A. N. Engl. J. Med. (1998) [Pubmed]
  3. Production rates and turnover of triiodothyronine in rat-developing cerebral cortex and cerebellum. Responses to hypothyroidism. Silva, J.E., Matthews, P.S. J. Clin. Invest. (1984) [Pubmed]
  4. Role of granulocyte oxygen products in damage of Schistosoma mansoni eggs in vitro. Kazura, J.W., de Brito, P., Rabbege, J., Aikawa, M. J. Clin. Invest. (1985) [Pubmed]
  5. Influence of methimazole on murine thyroiditis. Evidence for immunosuppression in vivo. Davies, T.F., Weiss, I., Gerber, M.A. J. Clin. Invest. (1984) [Pubmed]
  6. Olfaction and peripheral olfactory connections in methimazole-treated rats. Xu, W., Slotnick, B. Behav. Brain Res. (1999) [Pubmed]
  7. Perinatal hypothyroidism effects on neuromotor competence, novelty-directed exploratory and anxiety-related behaviour and learning in rats. Darbra, S., Garau, A., Balada, F., Sala, J., Martí-Carbonell, M.A. Behav. Brain Res. (2003) [Pubmed]
  8. Gender-specific changes in thyroid hormone-glucuronidating enzymes in rat liver during short-term fasting and long-term food restriction. Visser, T.J., van Haasteren, G.A., Linkels, E., Kaptein, E., van Toor, H., de Greef, W.J. Eur. J. Endocrinol. (1996) [Pubmed]
  9. Reversible cerebral hypoperfusion observed with Tc-99m HMPAO SPECT in reversible dementia caused by hypothyroidism. Kinuya, S., Michigishi, T., Tonami, N., Aburano, T., Tsuji, S., Hashimoto, T. Clinical nuclear medicine. (1999) [Pubmed]
  10. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group. Tallstedt, L., Lundell, G., Tørring, O., Wallin, G., Ljunggren, J.G., Blomgren, H., Taube, A. N. Engl. J. Med. (1992) [Pubmed]
  11. Carbimazole and the autoimmune response in Graves' disease. McGregor, A.M., Petersen, M.M., McLachlan, S.M., Rooke, P., Smith, B.R., Hall, R. N. Engl. J. Med. (1980) [Pubmed]
  12. Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Cooper, D.S., Goldminz, D., Levin, A.A., Ladenson, P.W., Daniels, G.H., Molitch, M.E., Ridgway, E.C. Ann. Intern. Med. (1983) [Pubmed]
  13. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha. Roti, E., Minelli, R., Giuberti, T., Marchelli, S., Schianchi, C., Gardini, E., Salvi, M., Fiaccadori, F., Ugolotti, G., Neri, T.M., Braverman, L.E. Am. J. Med. (1996) [Pubmed]
  14. Insulin autoimmunity as a cause of hypoglycemia. Benson, E.A., Ho, P., Wang, C., Wu, P.C., Fredlund, P.N., Yueng, R.T. Arch. Intern. Med. (1984) [Pubmed]
  15. Effect of methimazole, with or without L-thyroxine, on remission rates in Graves' disease. Rittmaster, R.S., Abbott, E.C., Douglas, R., Givner, M.L., Lehmann, L., Reddy, S., Salisbury, S.R., Shlossberg, A.H., Tan, M.H., York, S.E. J. Clin. Endocrinol. Metab. (1998) [Pubmed]
  16. Intrathyroidal concentrations of methimazole in patients with Graves' disease. Jansson, R., Dahlberg, P.A., Johansson, H., Lindström, B. J. Clin. Endocrinol. Metab. (1983) [Pubmed]
  17. Oxidative decarboxylation of free and peptide-linked amino acids in phagocytizing guinea pig granulocytes. Adeniyi-Jones, S.K., Karnovsky, M.L. J. Clin. Invest. (1981) [Pubmed]
  18. Association between the DRB1*08032 histocompatibility antigen and methimazole-induced agranulocytosis in Japanese patients with Graves disease. Tamai, H., Sudo, T., Kimura, A., Mukuta, T., Matsubayashi, S., Kuma, K., Nagataki, S., Sasazuki, T. Ann. Intern. Med. (1996) [Pubmed]
  19. Modulation by the thyroid state of intracellular calcium and contractility in ferret ventricular muscle. MacKinnon, R., Gwathmey, J.K., Allen, P.D., Briggs, G.M., Morgan, J.P. Circ. Res. (1988) [Pubmed]
  20. Postnatal mitochondrial differentiation in rat liver. Regulation by thyroid hormones of the beta-subunit of the mitochondrial F1-ATPase complex. Izquierdo, J.M., Luis, A.M., Cuezva, J.M. J. Biol. Chem. (1990) [Pubmed]
  21. Methimazole prevents induction of experimental systemic lupus erythematosus in mice. Singer, D.S., Kohn, L.D., Zinger, H., Mozes, E. J. Immunol. (1994) [Pubmed]
  22. Phenyl methimazole inhibits TNF-alpha-induced VCAM-1 expression in an IFN regulatory factor-1-dependent manner and reduces monocytic cell adhesion to endothelial cells. Dagia, N.M., Harii, N., Meli, A.E., Sun, X., Lewis, C.J., Kohn, L.D., Goetz, D.J. J. Immunol. (2004) [Pubmed]
  23. Properties of expressed and native flavin-containing monooxygenases: evidence of multiple forms in rabbit liver and lung. Lawton, M.P., Kronbach, T., Johnson, E.F., Philpot, R.M. Mol. Pharmacol. (1991) [Pubmed]
  24. Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor (rhG-CSF). Tamai, H., Mukuta, T., Matsubayashi, S., Fukata, S., Komaki, G., Kuma, K., Kumagai, L.F., Nagataki, S. J. Clin. Endocrinol. Metab. (1993) [Pubmed]
  25. Identification and characterization of novel genes modulated in the thyroid of dogs treated with methimazole and propylthiouracil. Wilkin, F., Savonet, V., Radulescu, A., Petermans, J., Dumont, J.E., Maenhaut, C. J. Biol. Chem. (1996) [Pubmed]
  26. Thyroid hormone stimulation of NADPH P450 reductase expression in liver and extrahepatic tissues. Regulation by multiple mechanisms. Ram, P.A., Waxman, D.J. J. Biol. Chem. (1992) [Pubmed]
  27. Mechanism of iodide-dependent catalatic activity of thyroid peroxidase and lactoperoxidase. Magnusson, R.P., Taurog, A., Dorris, M.L. J. Biol. Chem. (1984) [Pubmed]
  28. Reactions of purified hog thyroid peroxidase with H2O2, tyrosine, and methylmercaptoimidazole (goitrogen) in comparison with bovine lactoperoxidase. Ohtaki, S., Nakagawa, H., Nakamura, M., Yamazaki, I. J. Biol. Chem. (1982) [Pubmed]
  29. Iodide binding and regulation of lactoperoxidase activity toward thyroid goitrogens. Michot, J.L., Nunez, J., Johnson, M.L., Irace, G., Edelhoch, H. J. Biol. Chem. (1979) [Pubmed]
  30. Alternative processing events in human FMO genes. Lattard, V., Zhang, J., Cashman, J.R. Mol. Pharmacol. (2004) [Pubmed]
  31. Coupling of iodotyrosine catalyzed by human thyroid peroxidase in vitro. Sugawara, M. J. Clin. Endocrinol. Metab. (1985) [Pubmed]
  32. Analysis of IL-2 and IL-6 binding to peripheral blood lymphocytes in Graves disease: relationship with disease activity. Corrales, J.J., Orfao, A., López, A., Mories, M.T., Miralles, J.M., Ciudad, J. Cytometry. (1997) [Pubmed]
  33. Influence of hyperthyroidism on growth hormone secretion. Valcavi, R., Dieguez, C., Zini, M., Muruais, C., Casanueva, F., Portioli, I. Clin. Endocrinol. (Oxf) (1993) [Pubmed]
  34. Methimazole therapy in Graves' disease influences the abnormal expression of CD69 (early activation antigen) on T cells. Corrales, J.J., López, A., Ciudad, J., Mories, M.T., Miralles, J.M., Orfao, A. J. Endocrinol. (1997) [Pubmed]
  35. Frequency of antineutrophil cytoplasmic antibody in Graves' disease patients treated with methimazole. Gumà, M., Salinas, I., Reverter, J.L., Roca, J., Valls-Roc, M., Juan, M., Olivé, A. J. Clin. Endocrinol. Metab. (2003) [Pubmed]
  36. Enhanced activity of the purine nucleotide cycle of the exercising muscle in patients with hyperthyroidism. Fukui, H., Taniguchi , S., Ueta, Y., Yoshida, A., Ohtahara, A., Hisatome, I., Shigemasa, C. J. Clin. Endocrinol. Metab. (2001) [Pubmed]
  37. Arterial embolization: a novel approach to thyroid ablative therapy for Graves' disease. Xiao, H., Zhuang, W., Wang, S., Yu, B., Chen, G., Zhou, M., Wong, N.C. J. Clin. Endocrinol. Metab. (2002) [Pubmed]
  38. Methimazole has no dose-related effect on the intensity of the intrathyroidal autoimmune process in relapsing Graves' disease. Paschke, R., Vogg, M., Kristoferitsch, R., Aktuna, D., Wawschinek, O., Eber, O., Usadel, K.H. J. Clin. Endocrinol. Metab. (1995) [Pubmed]
  39. Methimazole pharmacology in man: studies using a newly developed radioimmunoassay for methimazole. Cooper, D.S., Bode, H.H., Nath, B., Saxe, V., Maloof, F., Ridgway, E.C. J. Clin. Endocrinol. Metab. (1984) [Pubmed]
WikiGenes - Universities